Discover

ORGO
Organogenesis Holdings Inc.
1.82
14 x 1.81
9 x 1.82
bid
ask
-
0.04
2.27%
01:40 PM
timesize
Ytd-64.91%
1y-60.57%
1.76
day range
1.89
1.54
52 week range
7.08
Open1.84Prev Close1.86Low1.76High1.89Mkt Cap233.88M
Vol464.18KAvg Vol973.60KEPS0.03P/E60.59Forward P/E-79.50
Beta1.34Short Ratio11.35Inst. Own48.25%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg2.42200-d Avg3.401yr Est5.00
Income Statement
Total Revenue43.76M
Revenues (USD)43.76M
Cost of Revenue23.67M
Gross Profit20.08M
Operating Expenses71.07M
Research and Development Expense18.30M
Selling, General and Administrative Expense53.97M
Operating Income-50.99M
Income Tax Expense45.39M
Net Income-96.27M
Net Income Common Stock-99.34M
Net Income Common Stock (USD)-99.34M
Consolidated Income-96.27M
Earnings per Basic Share-0.77
Earnings per Basic Share (USD)-0.77
Earnings per Diluted Share-0.77
Earning Before Interest & Taxes (EBIT)-50.88M
Earning Before Interest & Taxes (USD)-50.88M
Preferred Dividends Income Statement Impact3.07M
Weighted Average Shares128.67M
Weighted Average Shares Diluted128.67M
Balance Sheet
Cash and Equivalents46.84M
Cash and Equivalents (USD)46.84M
Trade and Non-Trade Receivables100.94M
Current Assets200.30M
Property, Plant & Equipment Net151.44M
Total Assets406.45M
Debt Current9.31M
Total Debt66.95M
Current Liabilities56.96M
Debt Non-Current57.64M
Total Liabilities118.31M
Accumulated Retained Earnings (Deficit)-152.50M
Shareholders Equity148.27M
Shareholders Equity (USD)148.27M
Assets Non-Current206.14M
Total Debt (USD)66.95M
Goodwill and Intangible Assets31.78M
Inventory29.28M
Liabilities Non-Current61.35M
Trade and Non-Trade Payables29.29M
Cash Flow
Depreciation, Amortization & Accretion6.59M
Net Cash Flow from Financing-12.50M
Net Cash Flow / Change in Cash & Cash Equivalents-45.25M
Capital Expenditure-1.10M
Issuance (Repayment) of Debt Securities -348.00K
Net Cash Flow from Investing-1.10M
Net Cash Flow from Operations-31.65M
Share Based Compensation3.05M